-
2024-519655-28-00
5
Premenopausal patients with high-risk HR-positive/HER2-negative breast
-
2023-503829-18-00
4
2019-12-05
Acute myeloid leukemia
-
2024-516996-34-00
5
2012-04-12
oestrogen-receptor (ER)-positive HER2-negative breast carcinoma
-
2023-510557-42-00
4
2017-07-10
chronic lymphocytic leukemia
Showing 1–4 of 4 trials